EMCIP
ZYME icon

Ewing Morris & Co Investment Partners’s Zymeworks ZYME Stock Holding History

Ewing Morris & Co Investment Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Hold
10,850
– – 0.15% 83
2026
Q1 		$272K Hold
10,850
– – 0.12% 78
2025
Q4 		$289K Hold
10,850
– – 0.13% 85
2025
Q3 		$185K Buy
+10,850
New +$155K 0.08% 92

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Ewing Morris & Co Investment Partners's ZYME Position: Q2 2026 in Review

Ewing Morris & Co Investment Partners held its Zymeworks (ZYME) position steady in Q2 2026 at 10,850 shares worth $284K. The position accounts for 0.15% of the portfolio, ranked #83.

Ewing Morris & Co Investment Partners first reported a position in ZYME in Q3 2025 and has held it in 4 quarters since. The position peaked at $289K in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Ewing Morris & Co Investment Partners held 10,850 shares of Zymeworks worth $284K as of Q2 2026.
  • Ewing Morris & Co Investment Partners left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up 0.15% of Ewing Morris & Co Investment Partners's portfolio in Q2 2026, its #83 holding.
  • Ewing Morris & Co Investment Partners first reported a position in Zymeworks in Q3 2025 and has held it in 4 quarters since.
  • Ewing Morris & Co Investment Partners's Zymeworks position peaked at $289K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Ewing Morris & Co Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.